sodium glycerophosphate anhydrous
Trade name: Glycophos
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
1
Earliest trial started Sep 15, 2020 (NCT04519762)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- PhosphateSupplementation
Phosphate supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSYP1H63LJ2K ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06651892 | Phase 2/Phase 3 (Phase 3) | May 1, 2024 | Ain Shams University |
| NCT04519762 | Phase 4 | Sep 15, 2020 | Ain Shams University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ain Shams University | Academic/Hospital | 2 | 2 | 2 | 2020 |
1 organizations
Page 1 / 1